688105.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:00):

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials...

Stats
Today's Volume	1.51M
Average Volume	2.58M
Market Cap	10.31B
EPS	CNY0.0100 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-45.25
ATR14	CNY0.0270 (0.11%)

Volume Correlation

Long: -0.12 (neutral)

Short: -0.03 (neutral)

Signal:(47.389) Neutral

Nanjing Vazyme Biotech Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanjing Vazyme Biotech Correlation - Currency/Commodity

-0.48
( neutral )

-0.56
( weak negative )

0.00
( neutral )

-0.73
( moderate negative )

0.16
( neutral )

0.61
( weak )

Nanjing Vazyme Biotech Financials

Annual	2023
Revenue:	CNY1.29B
Gross Profit:	CNY1.29B (100.00 %)
EPS:	CNY-0.180

Q4	2023
Revenue:	CNY417.55M
Gross Profit:	CNY300.30M (71.92 %)
EPS:	CNY0.0185

Q3	2023
Revenue:	CNY298.26M
Gross Profit:	CNY203.81M (68.33 %)
EPS:	CNY0.0118

Q2	2023
Revenue:	CNY268.84M
Gross Profit:	CNY205.27M (76.35 %)
EPS:	CNY-0.0762

Financial Reports:

No articles found.

Nanjing Vazyme Biotech

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.